Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 114-120 , February 2010

Endothelial Function and Arterial Compliance are not Impaired in Subjects With Heart Failure of Non-Ischemic Origin

  • Ashish Shah, MD

      Affiliations

    • Department of Clinical Pharmacology, Cardiovascular Division, School of Medicine, King's College London, London, UK
    • ,
  • Eugenia Gkaliagkousi, MD, PhD

      Affiliations

    • Department of Clinical Pharmacology, Cardiovascular Division, School of Medicine, King's College London, London, UK
    • ,
  • James M. Ritter, BM, DPHIL

      Affiliations

    • Department of Clinical Pharmacology, Cardiovascular Division, School of Medicine, King's College London, London, UK
    • ,
  • Albert Ferro, MB, PhD

      Affiliations

    • Department of Clinical Pharmacology, Cardiovascular Division, School of Medicine, King's College London, London, UK
    • Corresponding Author InformationReprint requests: Professor Albert Ferro, King's College London, 3.07 Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UK. Tel +44 20 7848 4283; Fax +44 20 7848 3743.

Received 11 May 2009 ,Revised 4 October 2009 ,Accepted 8 October 2009.

References 

  1. Eriksson H, Wilhelmsen L, Caidahl K, Svärdsudd K. Epidemiology and prognosis of heart failure. Z Kardiol. 1991;80(Suppl 8):1–6
  2. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–306
  3. Prasad A, Higano ST, Al Suwaidi J, Holmes DR, Mathew V, Pumper G, et al. Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction. Am Heart J. 2003;146:549–554
  4. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990;81:772–779
  5. Bachetti T. Endothelial dysfunction in chronic heart failure: some new basic mechanisms. Ital Heart J. 2000;1:656–661
  6. Mathier MA, Rose GA, Fifer MA, Miyamoto MI, Dinsmore RE, Castaño HH, et al. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1998;32:216–224
  7. Bank AJ, Lee PC, Kubo SH. Endothelial dysfunction in patients with heart failure: relationship to disease severity. J Card Fail. 2000;6:29–36
  8. Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92:395–399
  9. Yufu K, Takahashi N, Hara M, Saikawa T, Yoshimatsu H. Measurement of the brachial-ankle pulse wave velocity and flow-mediated dilatation in young, healthy smokers. Hypertens Res. 2007;30:607–612
  10. Benetos A, Waeber B, Izzo J, Mitchell G, Resnick L, Asmar R, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens. 2002;15:1101–1108
  11. Arnold JM, Marchiori GE, Imrie JR, Burton GL, Pflugfelder PW, Kostuk WJ. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and hemodynamics. Circulation. 1991;84:2418–2425
  12. Mitchell GF, Moyé LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation. 1997;96:4254–4260
  13. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol. 1999;33:951–958
  14. Aronson D, Burger AJ. Relation between pulse pressure and survival in patients with decompensated heart failure. Am J Cardiol. 2004;93:785–788
  15. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918–925
  16. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589–1596
  17. Drexler H, Hayoz D, Münzel T, Hornig B, Just H, Brunner HR, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596–1601
  18. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310–314
  19. Meyer B, Mörtl D, Strecker K, Hülsmann M, Kulemann V, Neunteufl T, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol. 2005;46:1011–1018
  20. Nakamura M, Sugawara S, Arakawa N, Nagano M, Shizuka T, Shimoda Y, et al. Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure. J Card Fail. 2004;10:36–42
  21. Stolen KQ, Kemppainen J, Kalliokoski KK, Karanko H, Toikka J, Janatuinen T, et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;93:64–68
  22. Mitchell GF, Tardif JC, Arnold JM, Marchiori G, O'Brien TX, Dunlap ME, et al. Pulsatile hemodynamics in congestive heart failure. Hypertension. 2001;38:1433–1439
  23. Weber T, Auer J, Lamm G, O'Rourke MF, Eber B. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification. J Card Fail. 2007;13:353–359
  24. Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension. 2002;39:1083–1087
  25. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002;15(1 Pt 1):24–30
  26. Giannattasio C, Vincenti A, Failla M, Capra A, Cirò A, De Ceglia S, et al. Effects of heart rate changes on arterial distensibility in humans. Hypertension. 2003;42:253–256
  27. Nürnberger J, Opazo Saez A, Dammer S, Mitchell A, Wenzel RR, Philipp T, et al. Left ventricular ejection time: a potential determinant of pulse wave velocity in young, healthy males. J Hypertens. 2003;21:2125–2132
  28. Tartière JM, Logeart D, Safar ME, Cohen-Solal A. Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure. J Hum Hypertens. 2006;20:213–219
  29. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37:1429–1433
  30. Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, et al. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J. 2005;26:1759–1764
  31. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435
  32. Johnston GD, Nicholls DP, Kondowe GB, Finch MB. Comparison of the acute vascular effects of frusemide and bumetanide. Br J Clin Pharmacol. 1986;21:359–364
  33. Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007;50:852–858
  34. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci. 2002;103:371–377

 A.S. was supported by a doctoral studentship from Pfizer plc; E.G. was supported by the Greek Foundation for State Scholarships.

PII: S1071-9164(09)01129-4

doi: 10.1016/j.cardfail.2009.10.019

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 114-120 , February 2010

Article Tools

* Image Usage & Resolution